Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa

OBJECTIVES: The high cost of rifampicin‐resistant tuberculosis (RR‐TB) treatment hinders treatment access. South Africa has a high RR‐TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR‐TB treatment by drug r...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Helen, Ramma, Lebogang, Wilkinson, Lynne, Azevedo, Virginia, Sinanovic, Edina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864411/
https://www.ncbi.nlm.nih.gov/pubmed/25975868
http://dx.doi.org/10.1111/tmi.12544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864411/
https://www.ncbi.nlm.nih.gov/pubmed/25975868
http://dx.doi.org/10.1111/tmi.12544

Ejemplares similares